1997
DOI: 10.1016/s0306-3623(96)00580-0
|View full text |Cite
|
Sign up to set email alerts
|

Effects of cAMP-Phosphodiesterase Isozyme Inhibitor on Cytokine Production by Lipopolysaccharide-Stimulated Human Peripheral Blood Mononuclear Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
31
0

Year Published

1999
1999
2015
2015

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 67 publications
(32 citation statements)
references
References 22 publications
1
31
0
Order By: Relevance
“…The intracellular level of cyclic nucleotides is regulated by their synthesis by adenylate (AC) 3 and guanylate cyclases and their hydrolysis into the corresponding inactive 5Ј-nucleotide monophosphates by phophodiesterases (PDE). Numerous studies show that selective PDE-4 inhibitors, such as rolipram and Ro-20-1724, attenuate TNF-␣ production in human monocytes and PBMC by elevation of the intracellular cAMP concentration (7)(8)(9)(10)(11). The cGMP analogues, dibutyryl cGMP (DB-cGMP) and 8-bromo-cGMP (8-Br-cGMP) were found to attenuate LPS-induced TNF-␣ secretion in primary monocytes and murine bone marrow-derived macrophages (8,12).…”
mentioning
confidence: 99%
“…The intracellular level of cyclic nucleotides is regulated by their synthesis by adenylate (AC) 3 and guanylate cyclases and their hydrolysis into the corresponding inactive 5Ј-nucleotide monophosphates by phophodiesterases (PDE). Numerous studies show that selective PDE-4 inhibitors, such as rolipram and Ro-20-1724, attenuate TNF-␣ production in human monocytes and PBMC by elevation of the intracellular cAMP concentration (7)(8)(9)(10)(11). The cGMP analogues, dibutyryl cGMP (DB-cGMP) and 8-bromo-cGMP (8-Br-cGMP) were found to attenuate LPS-induced TNF-␣ secretion in primary monocytes and murine bone marrow-derived macrophages (8,12).…”
mentioning
confidence: 99%
“…It was previously reported that subtype non-selective PDE4 inhibitors strongly suppressed LPS-stimulated TNF-a release but IL-1b or IL-6 release were partial or absent from human monocytes (9,10). Rofl umilast and cilomolast inhibited the TNF-a production in a concentration-dependent manner (Fig.…”
Section: Inhibitory Eff Ect Of Compound a On Lps-induced Tnf-α Releasmentioning
confidence: 70%
“…Several investigators reported that milrinone and other PDE inhibitors have the potential to inhibit inflammatory cell activation, 11 e.g. milrinone suppressed the endotoxin-stimulated production of TNF-alpha and IL-1 beta in human monocytes 12,13 and inhibited the respiratory burst of polymorphonuclear neutrophils to a certain degree. 1 4 Recently, Möllhoff et al 3 6 investigated the effects of milrinone on splanchnic oxygenation, systemic inflammation, and the subsequent acute-phase response in patients undergoing coronary artery bypass grafting.…”
Section: Discussionmentioning
confidence: 99%
“…However, milrinone has been shown to possess additional anti-inflammatory properties besides its cardiovascular effects. [11][12][13][14] Immune cells contain type IV and type III PDE, thus PDE inhibitors are potent regulators of various immune processes. Sepsis and endotoxemia lead to the activation and accumulation of leukocytes and circulatory disorders in several tissues.…”
Section: Laboratory Investigationsmentioning
confidence: 99%